Published in Eval Rev on February 01, 1999
Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral interventions. Psychosom Med (2011) 1.93
Modified therapeutic community for co-occurring disorders: a summary of four studies. J Subst Abuse Treat (2007) 1.09
How usual is usual care in pragmatic intervention studies in primary care? An overview of recent trials. Br J Gen Pract (2010) 1.04
Preference in random assignment: implications for the interpretation of randomized trials. Adm Policy Ment Health (2009) 0.96
The Healthy Teen Girls project: comparison of health education and STD risk reduction intervention for incarcerated adolescent females. Health Educ Behav (2011) 0.90
Modified therapeutic community for co-occurring disorders: single investigator meta analysis. Subst Abus (2010) 0.80
One-year stability, change and incidence in anxiety symptoms among early adolescents in the general population. Eur Child Adolesc Psychiatry (2012) 0.76
HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet (1996) 5.43
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health (1998) 2.28
Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health (2000) 2.09
Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health (2001) 2.02
Transformations of maps to investigate clusters of disease. Soc Sci Med (1988) 1.89
Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.87
Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob Agents Chemother (2003) 1.59
Inhibition of pyruvate dehydrogenase complex (PDHC) by antipsychotic drugs. Biol Psychiatry (1991) 1.41
A general hospital day program combining peer-led and professional treatment of cocaine abusers. Hosp Community Psychiatry (1993) 1.39
Motivation and readiness for therapeutic community treatment among adolescents and adult substance abusers. Am J Drug Alcohol Abuse (1997) 1.33
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
A clinicopathological study of sinonasal neuroendocrine carcinoma and sinonasal undifferentiated carcinoma. Laryngoscope (2000) 1.24
Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care (2004) 1.22
Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999. J Acquir Immune Defic Syndr (2001) 1.21
Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. Am J Drug Alcohol Abuse (2000) 1.17
Clarifying the nature of therapeutic community treatment. The Survey of Essential Elements Questionnaire (SEEQ). J Subst Abuse Treat (1999) 1.16
Circumstance, motivation, readiness and suitability as correlates of treatment tenure. J Psychoactive Drugs (1986) 1.15
Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. Int J Clin Pract (2009) 1.15
New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res (1999) 1.14
Therapeutic communities: what are the retention rates? Am J Drug Alcohol Abuse (1984) 1.11
Repeatability and validity of a field kit for estimation of cholinesterase in whole blood. Occup Environ Med (1995) 1.07
Measuring client clinical progress in therapeutic community treatment. The therapeutic community Client Assessment Inventory, Client Assessment Summary, and Staff Assessment Summary. J Subst Abuse Treat (2000) 1.06
Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes. J Clin Microbiol (1996) 1.06
Monoclonal anti-A from a hybrid-myeloma: evaluating as a blood grouping reagent. Vox Sang (1980) 1.06
Treatment process in prison therapeutic communities: motivation, participation, and outcome. Am J Drug Alcohol Abuse (2001) 1.04
The therapeutic community: status and evolution. Int J Addict (1986) 1.02
Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci U S A (1997) 1.01
Fixed and dynamic predictors of client retention in therapeutic communities. J Subst Abuse Treat (1993) 0.99
Phoenix House. Changes in psychopathological signs of resident drug addicts. Arch Gen Psychiatry (1973) 0.98
The orthopedic aspects of Gaucher disease. Clin Orthop Relat Res (1979) 0.95
Treatment for MICAs: design and implementation of the modified TC. J Psychoactive Drugs (1999) 0.95
Gaucher's disease in Southern Africa. S Afr Med J (1974) 0.94
Monoclonal anti-A and anti-B: development as cost-effective reagents. Med Lab Sci (1982) 0.94
Visceral leishmaniasis: a rare imported disease. J Infect (1983) 0.93
Modified therapeutic community for mentally ill chemical "abusers": background; influences; program description; preliminary findings. Subst Use Misuse (1997) 0.93
Therapeutic communities: diversity in treatment elements. Subst Use Misuse (2001) 0.92
Criminal involvement of cocaine users enrolled in a methadone treatment program. Addiction (1993) 0.92
Modified therapeutic community treatment for homeless dually diagnosed men. Who completes treatment? J Subst Abuse Treat (1998) 0.92
Therapeutic community methods in methadone maintenance (Passages): an open clinical trial. Drug Alcohol Depend (1995) 0.90
Modified therapeutic community for homeless mentally ill chemical abusers. Sociodemographic and psychological profiles. J Subst Abuse Treat (1999) 0.89
Male and female drug abusers: social and psychological status 2 years after treatment in a therapeutic community. Am J Drug Alcohol Abuse (1982) 0.88
The therapeutic community: success and improvement rates 5 years after treatment. Int J Addict (1982) 0.88
Manpower information and the community mental health system. Hosp Community Psychiatry (1986) 0.87
Phoenix House: psychopathological signs among male and female drug-free residents. Addict Dis (1974) 0.87
Fracture-dislocation of the base of the fifth metacarpal associated with injury to the deep motor branch of the ulnar nerve: a case report. J Hand Surg Am (1986) 0.87
Modified therapeutic community for homeless mentally ill chemical abusers: emerging subtypes. Am J Drug Alcohol Abuse (1999) 0.86
A difference in the in vivo cerebral production of [1-14C] lactate from D-[3-14C] glucose in chronic mental patients. J Neurosci Res (1981) 0.85
Homelessness and mental illness in a professional- and peer-led cocaine treatment clinic. Psychiatr Serv (1998) 0.85
Phoenix House. Criminal activity of dropouts. JAMA (1972) 0.85
A 16-year-old male with Noonan's syndrome develops progressive scoliosis and deteriorating gait. Pediatr Neurosurg (1999) 0.84
Pharmacokinetics of rufloxacin in patients with impaired renal function. Antimicrob Agents Chemother (1993) 0.84
Chronic Gaucher's disease: radiological findings in 17 South African cases. Br J Radiol (1975) 0.83
Conversion of glucose phosphate-14C to glucose-14C in passage through human brain in vivo. J Appl Physiol (1968) 0.83
Correlates of drug injection behaviors among methadone outpatients. Am J Drug Alcohol Abuse (1993) 0.83
Therapeutic communities and treatment research. NIDA Res Monogr (1994) 0.82
Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA. Immunogenetics (1999) 0.82
Atretic encephalocele. Pediatr Neurosurg (1998) 0.82
Prenatal diagnosis of chromosome mosaicism. Prenat Diagn (1984) 0.81
Hemodynamic changes during prostatectomy in cardiac patients. Crit Care Med (1982) 0.81
Total hip arthroplasty in Gaucher's disease. Long-term prognosis. Clin Orthop Relat Res (1988) 0.81
Alcohol: the hidden drug among substance abusers. Br J Addict (1989) 0.81
A client-treatment matching protocol for therapeutic communities: first report. J Subst Abuse Treat (2001) 0.81
Case histories and shorter communications. Conditioning functional enuresis: follow-up after retraining. Behav Res Ther (1983) 0.80
Crack/cocaine abusers in the general hospital: assessment and initiation of care. Am J Psychiatry (1992) 0.80
Bone involvement in Gaucher disease. Prog Clin Biol Res (1982) 0.80
Comparison of extradural fentanyl, bupivacaine and two fentanyl-bupivacaine mixtures of pain relief after abdominal surgery. Br J Anaesth (1995) 0.80
15-year-old young woman with brachial plexus tumor. Pediatr Neurosurg (1997) 0.79
A role for extracellular signal-regulated kinases 1 and 2 in the maintenance of persistent mechanical hyperalgesia in ovariectomized mice. Neuroscience (2010) 0.79
A comparison of conditioning and psychotherapy in the treatment of functional enuresis. J Clin Psychol (1966) 0.79
Anterior interbody fusion of the lumbar spine. Indications and results in 200 cases. Clin Orthop Relat Res (1966) 0.79
Psychiatric diagnoses among substance abusers in therapeutic community treatment. J Psychoactive Drugs (1986) 0.78
Psychological changes associated with conditioning functional enuresis. J Clin Psychol (1974) 0.78
Amino acid analysis using 1-naphthylisocyanate as a precolumn high performance liquid chromatography derivatization reagent. Anal Biochem (1989) 0.78
Service use and cost by mentally ill chemical abusers: differences by retention in a therapeutic community. J Subst Abuse (2000) 0.78
Atrophy of the left lobe of the liver and anomalous hepatic vessel in a patient with Yunis-Varon syndrome. J Clin Gastroenterol (1999) 0.77
Adolescents in therapeutic communities: one-year posttreatment outcomes. J Psychoactive Drugs (2000) 0.77
Modified therapeutic community for mentally ill chemical abusers: outcomes and costs. Eval Health Prof (1999) 0.77
Competitive inhibition by human sera of mouse monoclonal antibody binding to glycoproteins C and D of herpes simplex virus types 1 and 2. J Virol (1985) 0.77
Training the disturbed enuretic. Behav Res Ther (1978) 0.77
Adolescent amphetamine users in treatment: client profiles and treatment outcomes. J Psychoactive Drugs (2000) 0.76
Antibody to lymphadenopathy-associated virus/human T lymphotropic virus type III in various groups of illicit drug abusers in New York City. J Infect Dis (1985) 0.76
Cerebral uptake of amino acids in human subjects and rhesus monkeys in vivo. J Neurosci Res (1982) 0.75
Classical conditioning and extinction of human systolic blood pressure. Cond Reflex (1973) 0.75
Heroin addiction: its relation to sexual behavior and sexual experience. J Abnorm Psychol (1973) 0.75
Do antepartum herpes simplex virus cultures predict intrapartum shedding for pregnant women with recurrent disease? Infect Dis Obstet Gynecol (1999) 0.75
Population decentralization within metropolitan areas: 1970-1980. J Urban Econ (1990) 0.75
[Effects of a fish oil rich in eicosapentaenoic acid in dislipidemias]. Rev Med Chil (1987) 0.75
Program-based evaluation research in therapeutic communities. NIDA Res Monogr (1984) 0.75